Literature DB >> 32533226

A new fluorescence sensor developed with polydopamine nanospheres for the detection of anti-PLA2R antibody biomarkers of idiopathic membranous nephropathy.

Linlin Li1, Heng Lu2, Hong Ye1, Qi Zou1, Qiaoling Chen1, Lixin Wei3, Jingxi Zhang4.   

Abstract

Anti-PLA2R antibody is only expressed in podocytes from patients with idiopathic membranous nephropathy (IMN). The detection of anti-PLA2R antibody in serum is therefore able to obtain essential information for rapid diagnosis and evaluation of the disease activity of IMN. In the present study, a polydopamine nanosphere-based fluorescent sensor was constructed for direct detection of anti-PLA2R antibodies in human serum. In this sensing system, the double-stranded DNA was phosphorylated under the action of anti-PLA2R antibody and the single-stranded DNA was cut by exonuclease. The single-stranded DNA was then adsorbed on polydopamine microspheres. The fluorescent groups labeled on the DNA were quenched, and the concentration of anti-PLA2R antibody was detected quantitatively by measuring the fluorescence signal changes before and after the reaction. The experimental results show that the method has a good linear detection range between 0.05 and 10 μg/mL for anti-PLA2R antibody and the detection limit is 0.02 μg/mL. Graphical abstract.

Entities:  

Keywords:  Anti-PLA2R antibodies; Fluorescent sensors; Polydopamine microspheres

Mesh:

Substances:

Year:  2020        PMID: 32533226     DOI: 10.1007/s00216-020-02703-8

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  1 in total

1.  Clinical Evaluation of Antiphospholipase A2 Receptor IgG4 level and Its IgG4-to-IgG Ratio Based on Quantitative Immunoassays in Idiopathic Membranous Nephropathy.

Authors:  Yi Zhang; Yiqing Huang; Biao Huang; Xiaolei Chen; Bin Zhou; Pei Zou; Liang Wang; Xiaobin Liu; Huiming Sheng; Minhao Xie
Journal:  Biomed Res Int       Date:  2022-05-13       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.